DUBLIN–(BUSINESS WIRE)–The “Czech
Republic’s Pharma & Healthcare Market 2019-2020” report has
been added to ResearchAndMarkets.com’s offering.
This report provides a complete and detailed analysis of the healthcare
and pharmaceutical sector for the Czech Republic . The researcher
presents in-depth business intelligence in a standard format across
countries and regions, providing a balanced mix between analysis and
data.
The gross value added (GVA) of the Czech pharmaceutical sector amounted
to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector
accounted for 0.4% of the GDP that year. The pharmaceutical sector
employed 9,855 workers in 2017, accounting for 0.2% of the total number
of employees.
Total healthcare expenditures amounted to CZK 358.8bn in 2017,
increasing by 5.3% y/y, according to OECD data. The increase was mainly
due to public healthcare expenditures, which rose by 4% y/y to CZK
293.3bn, having a share of 81.7% of total healthcare expenditures. Total
healthcare expenditures accounted for 7.1% of GDP in 2017. The human
health and social work activities employed 294,300 people in 2017,
accounting for 7.3% of the total employment in the country.
What this report allows you to do:
-
Understand the key elements at play in the healthcare and
pharmaceutical sector in the Czech Republic - Access forecasts for growth in the sector
-
View key data on healthcare spending and health insurance in the Czech
Republic -
Crystallise the forces both driving and restraining this sector in the
Czech Republic - Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
-
Gain an understanding of the regulatory environment for the sector in
the Czech Republic -
Build a clear picture of trends and issues for sub-sectors (medical
institutions, pharmaceuticals manufacturing and distribution channels)
Key Topics Covered
01 EXECUTIVE SUMMARY
- Sector in Numbers
- Sector Overview
- Sector Snapshot
- Sector Outlook
- Sub-sector Outlook
- Driving Forces
- Restraining Forces
02 SECTOR IN FOCUS
- Main Economic Indicators
- Main Sector Indicators
- Pharmaceutical Output and Gross Value
- Added
- Pharmaceutical Production
- Sales
- New Orders
- Healthcare Expenditure
- Global Positioning
- Regional Positioning
- External Trade
- Foreign Direct Investments
- Employment and Wages
03 COMPETITIVE LANDSCAPE
- Timeline Czech Republic Pharma & Healthcare
- Highlights
- Top 20 Pharmaceutical Companies
- Top M&A Deals
- M&A Activity
04 COMPANIES IN FOCUS
- Teva Pharmaceuticals CR s.r.o.
- Zentiva k.s.
- FARMAK a.s.
- VUAB Pharma a.s.
- Bioveta a.s.
05 REGULATORY ENVIRONMENT
- Key Bodies
- Health Insurance System
- Government Policy VAT Rate
- VAT Rate for Medicines in Europe 2017
- Government Policy
06 HEALTHCARE SERVICES
- Highlights
- Main Events
- Healthcare Expenditures
- Healthcare Insurance Companies
- Life Expectancy
- Disease Trends and Risk Factors
- Number of Hospitals
- Cases of Hospitalisation
- Focus Point – Number of Hospitals by Region
- Number of Hospital Beds
- Focus Point – Number of Beds in Hospitals
- Healthcare Professionals
- Medical Equipment
07 PRESCRIPTION DRUGS
- Highlights
- Prescription Drug Sales
- Patented and Generic Drugs
08 OVER-THE-COUNTER DRUGS
- Highlights
- OTC Drug Sales
09 RETAIL CHANNELS
- Retail
For more information about this report visit https://www.researchandmarkets.com/r/wzqpw5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services, Pharmaceuticals